Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

1996-09-09

Original market date: See footnote 1

1973-12-31

Product name:

TEGOPEN INJ 250MG/VIAL

DIN:

00407593 Electronic product monograph is not available

Company:

BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB
300 2344 Boul. Alfred Nobel
Montreal
Quebec
Canada H4S 0A4

Class:

Human

Dosage form(s):

Powder For Solution

Route(s) of administration:

Intramuscular ,  Intravenous

Number of active ingredient(s):

1

Schedule(s):

Prescription

 

American Hospital Formulary Service (AHFS): See footnote 3

08:12.16.12 

Anatomical Therapeutic Chemical (ATC): See footnote 4

J01CF02 CLOXACILLIN

Active ingredient group (AIG) number:See footnote5

0105904001

List of active ingredient(s)
Active ingredient(s) Strength
CLOXACILLIN SODIUM 250 MG / VIAL
Version 4.0.2
Date modified: